COVID-19 診斷市場規模、佔有率和成長分析（按產品、樣本類型、測試類型、模式、最終用途和地區）- 2025-2032 年產業預測

2023 年 COVID-19 診斷市場規模價值 320.3 億美元，預計將從 2024 年的 385.0 億美元成長到 2032 年的 1677.6 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 20.2%。

2019 年 12 月，新冠肺炎疫情在中國武漢爆發，已造成全球超過 60 億人死亡，對全球健康經濟造成嚴重影響。該病毒的迅速傳播導致世界衛生組織於 2020 年 3 月宣布為大流行病。醫療保健系統不堪重負，迫切需要在診斷和治療方法取得進展。同時，封鎖措施加劇了經濟困難，失業率和通貨膨脹上升導致全球GDP下降。研究工作集中在 205 種潛在治療方法和 124 種疫苗上，特別是免疫療法、抗病毒藥物和細胞療法。重點研究領域包括抗體開發和基於 RNA 的疫苗，凸顯了對病毒的全面資料的需求，以製定有效的解決方案並確保公共衛生的復原力。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

COVID-19 診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 裝置
• 試劑和套件
• 服務

COVID-19 診斷市場規模（按樣本類型和複合年成長率）（2025-2032 年）

• 市場概況
• 鼻咽拭子（NP）
• 口咽拭子
• 鼻拭子
• 血
• 其他

COVID-19 診斷市場規模（按檢測類型和複合年成長率） (2025-2032)

• 市場概況
• 分子（PCR）檢測
• 抗原檢測
• 抗體（血清學）檢測
• 其他

COVID-19 診斷市場規模（按模式和複合年成長率）（2025-2032 年）

• 市場概況
• 照護現場(PoC)
• 非照護現場(Non-PoC)

COVID-19 診斷市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 研究所
• 醫院
• 診斷中心和診所
• 其他

COVID-19 診斷市場規模（按地區）及複合年成長率（2025-2032 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific（United States）
• Hologic, Inc.（United States）
• QuidelOrtho Corporation（United States）
• QIAGEN NV（Netherlands）
• bioMerieux（France）
• Laboratory Corporation of America Holdings（Labcorp）（United States）
• Abbott Laboratories（United States）
• F. Hoffmann-La Roche AG（Switzerland）
• Siemens Healthineers AG（Germany）
• Becton, Dickinson and Company（BD）（United States）
• PerkinElmer, Inc.（United States）
• Danaher Corporation（United States）
• Bio-Rad Laboratories, Inc.（United States）
• OraSure Technologies, Inc.（United States）
• Luminex Corporation（United States）
• Seegene Inc.（South Korea）
• Tecan Group Ltd.（Switzerland）

結論和建議

COVID-19 Diagnostics Market size was valued at USD 32.03 billion in 2023 and is poised to grow from USD 38.5 billion in 2024 to USD 167.76 billion by 2032, growing at a CAGR of 20.2% during the forecast period (2025-2032).

The COVID-19 pandemic has profoundly affected global health and economies, originating in Wuhan, China, in December 2019 and subsequently leading to over 6 billion deaths worldwide. The rapid spread of the virus prompted the World Health Organization to declare it a pandemic in March 2020. Health systems are overwhelmed, necessitating urgent advancements in diagnosis and treatment options. Concurrently, lockdown measures have exacerbated economic difficulties, with rising unemployment and inflation contributing to global GDP decline. Research efforts are focused on 205 potential therapies and 124 vaccines, particularly in immunotherapy, antivirals, and cell-based treatments. Key areas of investigation include antibody development and RNA-based vaccines, highlighting the critical need for comprehensive data on the virus to inform effective solutions and ensure public health resilience.

Top-down and bottom-up approaches were used to estimate and validate the size of the Covid-19 Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Covid-19 Diagnostics Market Segments Analysis

Global COVID-19 Diagnostics Market is segmented by Product, Sample Type, Test Type, Mode, End-use and region. Based on Product, the market is segmented into Instruments, Reagents & Kits and Services. Based on Sample Type, the market is segmented into Nasopharyngeal (NP)swabs, Oropharyngeal (OP) swabs, Nasal swabs, Blood and Others. Based on Test Type, the market is segmented into Molecular (PCR) Testing, Antigen-based Testing, Antibody (Serology) Testing and Others. Based on Mode, the market is segmented into Point-of-Care (PoC) and Non-Point-of-Care (Non-PoC). Based on End-use, the market is segmented into Laboratories, Hospitals, Diagnostic Centers and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Covid-19 Diagnostics Market

The COVID-19 diagnostics market has experienced significant growth due to the global response to the pandemic, as governments implemented lockdowns and invested heavily in healthcare and life sciences. This support catalyzed the rapid development of diagnostic tests and treatments for the virus. Furthermore, the FDA introduced an emergency use authorization (EUA) pathway, allowing for the swift approval of various therapies aimed at combatting COVID-19. Consequently, numerous pharmaceutical, biotechnology, and biopharmaceutical companies received EUA approvals, facilitating ongoing clinical studies and bolstering innovation in diagnostics. These concerted efforts have been pivotal in addressing the health crisis and enhancing diagnostic capabilities worldwide.

Restraints in the Covid-19 Diagnostics Market

One significant obstacle hindering the progress of the Covid-19 diagnostics market is the insufficient information regarding the novel coronavirus, particularly its biological and genetic characteristics, as well as the longevity of immunity in individuals who have recovered from the virus. This knowledge is crucial for the creation of safe and effective diagnostic solutions. Furthermore, as the industry moves forward, it must navigate challenges related to production capacity and distribution logistics. Consequently, alongside ongoing vaccine development, manufacturers are prioritizing the enhancement of their production capabilities to address these emerging challenges effectively.

Market Trends of the Covid-19 Diagnostics Market

The Covid-19 diagnostics market has exhibited a significant shift towards in vitro diagnostics, with a strong emphasis on developing highly reliable and cost-effective testing solutions. As of July 2021, over 500 point-of-care (POC) diagnostic tests were available, reflecting a growing trend towards rapid testing that delivers faster results to facilitate timely decision-making. This surge in innovation is driven by collaboration between private companies and government initiatives to enhance public health response capabilities. The focus on improving test accuracy and accessibility underscores a market trajectory toward more sophisticated diagnostic technologies, which are anticipated to shape ongoing pandemic management and preparedness for future outbreaks.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global COVID-19 Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits
• Services

Global COVID-19 Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Nasopharyngeal (NP) swabs
• Oropharyngeal (OP) swabs
• Nasal swabs
• Blood
• Others

Global COVID-19 Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Molecular (PCR) Testing
• Antigen-based Testing
• Antibody (Serology) Testing
• Others

Global COVID-19 Diagnostics Market Size by Mode & CAGR (2025-2032)

• Market Overview
• Point-of-Care (PoC)
• Non-Point-of-Care (Non-PoC)

Global COVID-19 Diagnostics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Laboratories
• Hospitals
• Diagnostic Centers and Clinics
• Others

Global COVID-19 Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Sample Type, Test Type, Mode, End-use)
  • US
  • Canada
• Europe (Product & Service, Sample Type, Test Type, Mode, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Sample Type, Test Type, Mode, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Sample Type, Test Type, Mode, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Sample Type, Test Type, Mode, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations